DURHAM, N.C., March 25, 2011 /PRNewswire/ — Centers for Disease
Control and Prevention has awarded $2 million to Duke University
Prevention Epicenter as part of its program to conduct innovative
research in the science of preventing Healthcare-Associated
Infections, or HAIs, with the goal of saving lives in healthcare
settings. The Tru-D germicidal disinfection system was selected by
Duke University after successful internal trials and published
third-party data provided reliable, repeatable results. Five Tru-D
instruments (Lumalier Corporation) will be deployed during the
first two years of the grant.
CDC’s Prevention Epicenters (PE) Program is a unique research
program in which CDC’s Division of Healthcare Quality Promotion
(DHQP) collaborates with academic investigators to conduct
innovative infection control and prevention research. CDC Director
Thomas R. Frieden, M.D., M.P.H., stated, “With Prevention
Epicenters, we can expand our current knowledge and save even more
lives as we work toward our goal of eliminating HAIs.” With the
emergence of drug-resistant pathogens, strategies to reduce
healthcare-associated infections are critical.
John Jernigan, M.D., M.S., director of CDC’s Office of HAI
Prevention Research and Evaluation, stated, “During the past
decade, some of our biggest breakthroughs in healthcare infection
prevention have been rooted in research of the Prevention Epicenter
program, and we look forward to future advances.” The Prevention
Epicenter program helps uncover and implement solutions to help
prevent infections, such as Tru-D Rapid Room Disinfection.
Published data indicate that Tru-D treatment eliminates
environmental pathogens that cause MRSA, VRE, Acinetobactor, C.
diff, and other acquired infections. Tru-D sensor technology
uniquely “reads” the disinfection dynamics of each room to deliver
a measured, lethal dose of germicidal energy within the room,
including shadowed areas. Actual, real-time disinfection
‘/>”/>
